biotech.today

Details

  • ●Modalities: small molecules
  • ●Therapeutic areas: oncology, inflammation
  • ●Key targets:
  • ●Indications: Undisclosed
  • ●Funding: $120M

Partners & investors

  • Column Group· Investor
  • NVIDIA· Investor
  • NVIDIA Ventures· Investor

Key considerations

  • ●AI tools in use: tNTR Platform
  • ●$120M Series B (2024) led by Nvidia Ventures + Column Group
  • ●First large Nvidia-led biotech bet
Get live updates on Terray Therapeutics’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Jacob Berlin

Co-Founder & CEO

combinatorial-chemistry
Visit website →LinkedIn →